Treat to target in Behcet's disease: Should we follow the paradigm of other systemic rheumatic diseases? - Immunologie-Immunopathologie-Immunothérapie Accéder directement au contenu
Article Dans Une Revue Clinical immunology (Orlando, Fla.) Année : 2023

Treat to target in Behcet's disease: Should we follow the paradigm of other systemic rheumatic diseases?

Domaines

Immunologie
Fichier non déposé

Dates et versions

hal-04024766 , version 1 (11-03-2023)

Identifiants

  • HAL Id : hal-04024766 , version 1

Citer

George E. Fragoulis, George Bertsias, Bahram Bodaghi, Ahmet Gul, Jan Van Laar, et al.. Treat to target in Behcet's disease: Should we follow the paradigm of other systemic rheumatic diseases?. Clinical immunology (Orlando, Fla.), 2023, 246, pp.109186. ⟨hal-04024766⟩
5 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More